[{"address1": "7 Golda Meir Street", "address2": "Weizmann Science Park", "city": "Ness Ziona", "zip": "7403650", "country": "Israel", "phone": "972 8 931 3433", "website": "https://www.sol-gel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Ms. Tamar  Fishman Jutkowitz", "age": 48, "title": "VP & General Counsel", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 271000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Moshe  Arkin", "age": 71, "title": "CEO & Executive Chairman", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eyal  Ben-Or", "age": 41, "title": "Chief Financial Officer", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzik  Yosef", "age": 48, "title": "Chief Operating Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 236000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Glezin", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.25, "open": 15.2226, "dayLow": 15.1424, "dayHigh": 15.7, "regularMarketPreviousClose": 15.25, "regularMarketOpen": 15.2226, "regularMarketDayLow": 15.1424, "regularMarketDayHigh": 15.7, "payoutRatio": 0.0, "beta": 1.222, "forwardPE": -32.166668, "volume": 11935, "regularMarketVolume": 11935, "averageVolume": 17959, "averageVolume10days": 19080, "averageDailyVolume10Day": 19080, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 43012132, "fiftyTwoWeekLow": 4.01, "fiftyTwoWeekHigh": 16.89, "priceToSalesTrailing12Months": 3.5538406, "fiftyDayAverage": 9.6903, "twoHundredDayAverage": 7.491835, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 27289166, "profitMargins": -1.07775, "floatShares": 689337, "sharesOutstanding": 2785760, "sharesShort": 19385, "sharesShortPriorMonth": 15161, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0069999998, "heldPercentInsiders": 0.70002997, "heldPercentInstitutions": 0.15754, "shortRatio": 1.7, "shortPercentOfFloat": 0.016900001, "impliedSharesOutstanding": 2785760, "bookValue": 10.356, "priceToBook": 1.490923, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -13044000, "trailingEps": -4.7, "forwardEps": -0.48, "lastSplitFactor": "1:10", "lastSplitDate": 1746403200, "enterpriseToRevenue": 2.255, "enterpriseToEbitda": -1.926, "52WeekChange": 2.2851064, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 15.44, "recommendationKey": "none", "totalCash": 16902000, "totalCashPerShare": 6.067, "ebitda": -14165250, "totalDebt": 1179000, "quickRatio": 4.545, "currentRatio": 5.124, "totalRevenue": 12103000, "debtToEquity": 5.845, "revenuePerShare": 4.345, "returnOnAssets": -0.26822, "returnOnEquity": -0.49388, "grossProfits": -9198000, "revenueGrowth": 1.212, "grossMargins": -0.75998, "ebitdaMargins": -1.17039, "operatingMargins": -8.796309, "financialCurrency": "USD", "symbol": "SLGL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 1.2459, "regularMarketPrice": 15.44, "shortName": "Sol-Gel Technologies Ltd.", "longName": "Sol-Gel Technologies Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1517495400000, "postMarketChangePercent": -1.9430003, "postMarketPrice": 15.14, "postMarketChange": -0.29999924, "regularMarketChange": 0.19, "regularMarketDayRange": "15.1424 - 15.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 17959, "fiftyTwoWeekLowChange": 11.429999, "fiftyTwoWeekLowChangePercent": 2.8503737, "fiftyTwoWeekRange": "4.01 - 16.89", "fiftyTwoWeekHighChange": -1.4499998, "fiftyTwoWeekHighChangePercent": -0.085849606, "fiftyTwoWeekChangePercent": 228.51064, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1763123400, "earningsTimestampEnd": 1763123400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.7, "epsForward": -0.48, "fiftyDayAverageChange": 5.7496996, "fiftyDayAverageChangePercent": 0.5933459, "twoHundredDayAverageChange": 7.9481645, "twoHundredDayAverageChangePercent": 1.0609102, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1755298319, "regularMarketTime": 1755288001, "exchange": "NCM", "messageBoardId": "finmb_621569", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Sol-Gel", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]